FDA-Drug2026-01-07Class IIPACKAGING DEFECT
Novo Nordisk Wegovy (semaglutide) injection recalled for hair found in prefilled pen
What this means
Novo Nordisk discovered hair in some prefilled Wegovy injection pens. This affects specific lot numbers manufactured in Denmark. No injuries have been reported.
- Check your Wegovy pen for lot number RZFHD52 or RZFHW93 (expiration 10/31/2026)
- Do not use affected pens
- Contact your pharmacy or doctor for a replacement
- Call Novo Nordisk customer service if you have questions
The agency's original wording
Hazard
Presence of Particulate Matter: Hair was found in a prefilled syringe
Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide within the United States.
Affected count
N/A
Manufactured in
800 Scudders Mill Rd, N/A, Plainsboro, NJ, United States
Products
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0244-2026Want us to check the next one for you?
We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.